arrow_back Back to App

Supporting Sickle Cell Disease Awareness Month: Promoting Research and Early Detection

The US Senate officially supported designating September 2023 as Sickle Cell Disease Awareness Month. This aims to educate communities about this serious inherited blood disorder, which affects approximately 100,000 Americans and severely limits life expectancy. The resolution encourages public events to promote research, early detection, and better access to preventative care and effective treatments for those suffering from SCD.
Key points
Increased public focus on Sickle Cell Disease (SCD), a severe inherited disorder requiring better management and awareness.
Promotion of early detection methods, preventative care programs, and available treatments to improve patient outcomes and quality of life.
Emphasis on the urgent need for further research to find widely available cures and innovative therapies for SCD.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_369
Sponsor: Sen. Scott, Tim [R-SC]
Process start date: 2023-09-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of September 2023 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_369.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-09-26.

What are the main provisions?

Key points include:

  • Increased public focus on Sickle Cell Disease (SCD), a severe inherited disorder requiring better management and awareness.
  • Promotion of early detection methods, preventative care programs, and available treatments to improve patient outcomes and quality of life.
  • Emphasis on the urgent need for further research to find widely available cures and innovative therapies for SCD.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Scott, Tim [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S4676; text: CR S4686-4687)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health